Monday, March 2, 2020

Defective Drug Lawyers Banville Law Investigating Zantac Cancer Claims

Banville Law - As early as the year 2019, the United States Food and Drug Administration (FDA) announced that some early tests had found that a chemical named N-nitrosodimethylamine, abbreviated NDMA, could be linked to several forms of cancer.

Most importantly, NDMA is one of the ingredients in the heartburn medication Zantac (whose brand name is Ranitidine), and long-term usage of the chemical could be potentially linked to various types of cancer including liver, stomach, kidney, pancreatic and more. For this reason, Banville Law has assembled a team of Zantac cancer lawsuit attorneys to investigate the latest medical research on the subject.

At this time, the U.S. FDA has encouraged manufacturers of NDMA to test and even recall drugs found to have toxic concentrations of the carcinogen. However, there is currently no public record of settlements as a result of Zantac causing cancer.

With over 15 million Zantac prascriptions being written each year, Laurence Banville believes it may only be a matter of time before legal action is taken, "Our defective drug attorneys have recently been made aware of lawsuits filed against pharmaceutical companies for failing to list NDMA, the chemical believed to be cancer-causing, as one of the ingredients in Zantac. In addition to this, we have also come across an analysis published on the Harvard Medical School website which explained how NDMA can be carcinogec. Since the publishing of that original article, the recall on ranitidine (Zantac) has only expanded, and national drugstore chains such as Walgreens and CVS have begun pulling versions of the drug, including the brand name, off the shelf."

Due to the severe nature of the health repercussions that extended use of Zantac can have, the Banville Law team have made the services of their defective drug lawyers available to all via free legal case reviews: "We invite any individuals who have been diagnosed with cancer after taking Zantac for a long period of time to contact our team as soon as possible. We will gladly discuss and explain their legal options, as they may have grounds for a cancer lawsuit," explaind Laurence Banville, Esq.

###

For more information about Banville Law, contact the company here:

Banville Law
Banville Law
(917) 551-6690
info@banvillelaw.com

No comments:

Post a Comment